Literature DB >> 24122930

Lower admission hemoglobin levels are associated with longer symptom duration in acute ST-elevation myocardial infarction.

Yacov Shacham1, Eran Leshem-Rubinow, Eyal Ben-Assa, Arie Roth, Arie Steinvil.   

Abstract

BACKGROUND: An acute-phase response in patients with acute myocardial infarction could contribute to the development of anemia. HYPOTHESIS: An association may exist between symptom duration, hemoglobin (Hb) concentration and serum C-reactive protein (CRP) values in patients presenting to an emergency department (ED) with acute ST-segment elevation myocardial infarction (STEMI).
METHODS: A retrospective analysis was conducted on consecutive male STEMI patients who were admitted to our medical center's ED from January 2008 to November 2012 and had presented within the first 12 hours after the onset of chest pain. Hemoglobin concentration and serum CRP levels were determined from blood samples taken prior to any drug or fluid administration. Analyses of variance were used to determine interactions between selected time-to-presentation cutoffs and admission Hb and CRP concentrations. Patients with other reasons known to cause elevation of inflammatory markers, anemia, or bleeding diathesis were excluded.
RESULTS: The study population comprised 718 patients whose mean age was 61 ± 12 years (range, 27-96 years). Blood was drawn for Hb and CRP measurements directly upon admission. Patients who presented to the ED within 3 hours of symptom onset had higher Hb concentrations (P = 0.048) and lower serum CRP levels (P < 0.001) compared with those who presented after a longer interval from symptom onset.
CONCLUSIONS: Longer symptom duration is associated with a lower admission Hb level and an early rise in the CRP level of male patients with acute STEMI.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24122930      PMCID: PMC6649392          DOI: 10.1002/clc.22215

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  9 in total

Review 1.  Acute kidney injury among ST elevation myocardial infarction patients treated by primary percutaneous coronary intervention: a multifactorial entity.

Authors:  Yacov Shacham; Arie Steinvil; Yaron Arbel
Journal:  J Nephrol       Date:  2016-02-10       Impact factor: 3.902

2.  Incidence and outcomes of early left ventricular thrombus following ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.

Authors:  Shafik Khoury; Sarit Carmon; Gilad Margolis; Gad Keren; Yacov Shacham
Journal:  Clin Res Cardiol       Date:  2017-04-10       Impact factor: 5.460

3.  Renal impairment according to acute kidney injury network criteria among ST elevation myocardial infarction patients undergoing primary percutaneous intervention: a retrospective observational study.

Authors:  Yacov Shacham; Eran Leshem-Rubinow; Arie Steinvil; Eyal Ben Assa; Gad Keren; Arie Roth; Yaron Arbel
Journal:  Clin Res Cardiol       Date:  2014-02-13       Impact factor: 5.460

4.  High sensitive C-reactive protein and the risk of acute kidney injury among ST elevation myocardial infarction patients undergoing primary percutaneous intervention.

Authors:  Yacov Shacham; Eran Leshem-Rubinow; Arie Steinvil; Gad Keren; Arie Roth; Yaron Arbel
Journal:  Clin Exp Nephrol       Date:  2014-12-10       Impact factor: 2.801

5.  Anemia and Inflammation in ST-Segment Elevation Myocardial Infarction.

Authors:  Enyuan Zhang; Zhenyu Li; Jingjin Che; Xin Chen; Tiantian Qin; Qing Tong; Weiwei Zhao; Guangping Li
Journal:  Am J Med Sci       Date:  2015-06       Impact factor: 2.378

6.  Anemia: A significant cardiovascular mortality risk after ST-segment elevation myocardial infarction complicated by the comorbidities of hypertension and kidney disease.

Authors:  Wei-Chieh Lee; Hsiu-Yu Fang; Huang-Chung Chen; Chien-Jen Chen; Cheng-Hsu Yang; Chi-Ling Hang; Chiung-Jen Wu; Chih-Yuan Fang
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

7.  Anemia and Acute Coronary Syndrome: Time for Intervention Studies.

Authors:  Serdar Farhan; Usman Baber; Roxana Mehran
Journal:  J Am Heart Assoc       Date:  2016-11-19       Impact factor: 5.501

8.  Incremental Prognostic Value of Anemia in Acute Coronary Syndrome from A Rural Hospital in India.

Authors:  Anjalee Chiwhane; Shreerang Burchundi; Gajendra Manakshe; Hemant Kulkarni
Journal:  Glob Heart       Date:  2020-02-12

9.  Development of a nomogram for the prediction of in-hospital mortality in patients with acute ST-elevation myocardial infarction after primary percutaneous coronary intervention: a multicentre, retrospective, observational study in Hebei province, China.

Authors:  Yudan Wang; Wenjing Wang; Shengqi Jia; Man Gao; Shihang Zheng; Jiaqi Wang; Yi Dang; Yingxiao Li; Xiaoyong Qi
Journal:  BMJ Open       Date:  2022-02-02       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.